Brief: Prometheus Biosciences Posts Qtrly Loss Per Share $0.49
11/08/2021 22:22
Aug 11 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS
* Q2 REVENUE $300,000
* QTRLY LOSS PER SHARE $0.49
Source text for Eikon: ID:nGNX5kRNxQ
Further company coverage: RXDX.O
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results